Status:
WITHDRAWN
Autologous Blood Patch for Primary Spontaneous Pneumothorax
Lead Sponsor:
Rush University Medical Center
Conditions:
Primary Spontaneous Pneumothorax
Eligibility:
All Genders
13-18 years
Phase:
NA
Brief Summary
The purpose of this study is to show that treatment with prophylactic autologous blood patch (ABP) after management of primary spontaneous pneumothorax (PSP) is feasible, reduces the incidence of prol...
Detailed Description
The investigators will employ a novel treatment algorithm using a previously described technique to determine its feasibility and efficacy. This study will provide necessary quantitative and qualitati...
Eligibility Criteria
Inclusion
- Diagnosed with primary spontaneous pneumothorax (first occurrence) and meets criteria for chest tube placement or Diagnosed with recurrent primary spontaneous pneumothorax (recurrence) and meets criteria for blebectomy with a pleural procedure
- Between the ages of 13-18
Exclusion
- Known hematologic disorders Hemodynamic instability at the time of presentation
Key Trial Info
Start Date :
July 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2027
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT06088901
Start Date
July 1 2024
End Date
July 1 2027
Last Update
June 27 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rush University Medical Center
Chicago, Illinois, United States, 60612